Roche to Share New Data on Elecsys Alzheimer’s Blood Tests at AAIC
Presentations will evaluate the performance of the company's pTau217 and pTau181 assays while also highlighting phase 3 clinical research for the investigational therapy trontinemab for Alzheimer's disease.